|Bid||0.00 x 2200|
|Ask||0.00 x 1000|
|Day's Range||7.42 - 7.91|
|52 Week Range||2.89 - 12.44|
|Beta (5Y Monthly)||1.25|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Shares of Dynavax Technologies (NASDAQ: DVAX) were trading 5.4% lower as of 11:22 a.m. EDT on Tuesday. The decline came after the company announced the pricing of a $200 million offering of senior convertible notes. This represents a 32.5% premium over the closing price of the biotech stock on Monday.
Shares of Dynavax Technologies (NASDAQ: DVAX) were nosediving 18.1% lower as of 11:42 a.m. EDT on Monday. The key word to note in Dynavax's announcement is "convertible." Issuing convertible notes is a common practice for companies, though.
Dynavax Technologies Corporation ( NASDAQ:DVAX ) shareholders will have a reason to smile today, with the analysts...